Isotretinoin Capsule
NDC Package 84386-011-03
Package Information
Isotretinoin capsules is indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. This formulation utilizes a capsule delivery system. Marketed by Aurobindo Pharma Limited, this product is identified by NDC 84386-011 and is authorized under FDA application ANDA220336.
Identification & Billing
- RxCUI: 197844 - ISOtretinoin 20 MG Oral Capsule
- RxCUI: 197844 - isotretinoin 20 MG Oral Capsule
- RxCUI: 197845 - ISOtretinoin 40 MG Oral Capsule
- RxCUI: 197845 - isotretinoin 40 MG Oral Capsule
- RxCUI: 403930 - ISOtretinoin 30 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 84386 - Aurobindo Pharma Limited
- 84386-011 - Isotretinoin
- 84386-011-03 - 3 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK
- 84386-011 - Isotretinoin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84386-011-03 identifies a specific commercial package of 3 blister pack in 1 carton / 10 capsule in 1 blister pack of Isotretinoin, a human prescription drug labeled by Aurobindo Pharma Limited. This capsule is formulated for oral use and contains isotretinoin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurobindo Pharma Limited on September 10, 2026. The current certification is valid through December 31, 2027.
How is this Aurobindo Pharma Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84386001103. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.